CD8A and cancer: Significant level of cross-reactivity to highly homologous TAAs and microbiota-derived peptides was observed in both healthy donors and cancer patients, suggesting that anti-microbial CD8 + T cells may bind to TAAs expressed by cancer cells and play a key role in controlling tumor growth.